RxDoctor Payments Data

Aida Lugo-Somolinos, MD

Dermatology · Chapel Hill, NCNPI 1043207442

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Reporting peaked in 2019 at $361 and has fallen 82.0% since, to $65 in 2023. That places this record below the midpoint for dermatology clinicians in NC, where the typical reported total is $2,057.

$701in general payments, 2019–2025

Across 10 payments — averaging $70.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$361
  • Johnson & Johnson$340
$2,176,961in research payments, 2019–2025

Across 397 payments — averaging $5483.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$867K
  • Eli Lilly$591K
  • Novartis$272K
  • Janssen Research & Development, LLC$144K
  • AbbVie$103K
  • Incyte Corporation$65K
  • plus $135K from 5 others

What the payments were for

  • Travel & lodging$22432%
  • Food & beverage$13720%
  • Education$34049%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis5$361
Johnson & Johnson5$340

How this compares

$701 in reported general payments places this provider in the 30th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$59,182
Medicare patients
285
Services billed
1,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate19$579
Triamcinolone Acetonide13$122

Paid to pharmacies, not to this prescriber.

Other dermatology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →